No abstract

Besides its extreme climate conditions, the Caatinga (a type of tropical seasonal forest) hosts an impressive faunal and floristic biodiversity. In the last 50 years there has been a considerable increase in the number of studies in the area. Here we aimed to present a review of these studies, focusing on four main fields: vertebrate ecology, plant ecology, human ecology, and ethnobiology. Furthermore, we identify directions for future research. We hope that the present paper will help defining actions and strategies for the conservation of the biological diversity of the Caatinga.

We describe the medicinal plants that have been reported to be antitumor agents and that have been used in ethnobotanic research in Brazil to answer the following questions: what is the abundance of plants reported to be antitumor in Brazil? Have the plant species used for tumor treatment in traditional Brazilian medicine been sufficiently examined scientifically? Our analysis included papers published between 1980 and 2008. A total of 84 medicinal plant species were reported to be used for cancer and tumor prevention or treatment; 69.05% of these were cited as being used for the treatment of tumors and cancer in general and 30.95% for specific tumors or cancers. The plants that were cited at a higher frequency were Aloe vera, Euphorbia tirucalli, and Tabebuia impetiginosa. At least, one pharmacological study was found for 35.71% of the species. Majority of the studies selected were conducted in rural communities and urban areas and in areas with traditional healers in Brazil. We found the following molecules to be the most studied in vitro and in vivo: silibinin, β-lapachone, plumbagin and capsaicin. The species addressed here constitute interesting objects for future studies to various professionals in the field of natural products.

The objective of this study was to evaluate antiproliferative activity, antioxidant capacity and tannin content in plants from semi-arid northeastern Brazil (Caatinga). For this study, we selected 14 species and we assayed the methanol extracts for antiproliferative activity against the HEp-2 (laryngeal cancer) and NCI-H292 (lung cancer) cell lines using the (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazole) (MTT) method. In addition, the antioxidant activity was evaluated with the DPPH (2,2-diphenyl-2-picrylhydrazyl) assay, and the tannin content was determined by the radial diffusion method. Plants with better antioxidant activity (expressed in a dose able to decrease the initial DPPH concentration by 50%, or IC50) and with higher levels of tannins were: Poincianella pyramidalis (42.95 ± 1.77 µg/mL IC50 and 8.17 ± 0.64 tannin content), Jatropha mollissima (54.09 ± 4.36µg/mL IC50 and 2.35 ± 0.08 tannin content) and Anadenanthera colubrina (73.24 ± 1.47 µg/mL IC50 and 4.41 ± 0.47 tannin content). Plants with enhanced antiproliferative activity (% living cells) were Annona muricata (24.94 ± 0.74 in NCI-H292), Lantana camara (25.8 ± 0.19 in NCI-H292), Handroanthus impetiginosus (41.8 ± 0.47 in NCI-H292) and Mentzelia aspera (45.61 ± 1.94 in HEp-2). For species with better antioxidant and antiproliferative activities, we suggest future in vitro and in vivo comparative studies with other pharmacological models, and to start a process of purification and identification of the possible molecule(s) responsible for the observed pharmacological activity. We believe that the flora of Brazilian semi-arid areas can be a valuable source of plants rich in tannins, cytotoxic compounds and antioxidant agents.

Palavras-chave: plantas medicinais, fitoterápicos, controle de qualidade, produtos naturais, botânica aplicadaABSTRACT -(Quality of products made from medicinal plants commercialized in Brazil: horsechestnut (Aesculus hippocastanum L.), lemongrass (Cymbopogon citratus (DC.) Stapf), and gotu kola (Centella asiatica (L.) Urban). Aiming to evaluate the quality of products made from medicinal plants, there were analyzed ten samples of horsechestnut, eleven samples of lemongrass, and six samples of gotu kola commercialized in pharmacies from the city of Recife (Pernambuco, Brazil), coming from industries of several parts of the country. We analyzed the technical-scientific information on the labels and/or directions according to the requirements and obligations of Brazilian law (laws "RDC 140 of 29/05/2003" and "RDC 102 of 30/11/2000") and to scientific literature embasement. The products' organoleptic characteristics, authenticity, and purity were also evaluated. The absence of obligatory information was verified in 92.59% of the samples. Among the blacked terms, it was common to find products that suggested inexistent collateral or adverse effects. Technical terms were not standardized and the manufacturers did not provide scientific proof for some of the activities credited to the products. All samples were considered authentic based on the phytochemical and pharmacobotanical tests. The purity analysis considered 59.26% of the samples inappropriate, mainly due to the high total levels of humidity and ashes. It was verified that besides the lack of adequate information and quality of the commercialized products, there is an urgent need for an effective inspection by the suitable agencies.

There are several species of plants used by traditional communities in the Brazilian semiarid. An approach used in the search for natural substances that possess therapeutic value is ethnobotany or ethnopharmacology. Active substances that have phenolic groups in their structure have great pharmacological potential. To establish a quantitative relationship between the species popularly considered to be antimicrobial, antidiabetic, and antidiarrheal, the contents of tannins and flavonoids were determined. The plant selection was based on an ethnobotanical survey conducted in a community located in the municipality of Altinho, northeastern Brazil. For determination of tannin content was utilized the technique of radial diffusion, and for flavonoids, an assay based on the complexation of aluminum chloride. The group of plants with antimicrobial indications showed a higher content of tannins compared to the control groups. The results evidence suggests a possible relationship between these compounds and the observed activity.

A majority of the native medicinal plants that are commercialized in Brazil are harvested from natural populations. In addition to this essentially unrestrained collecting, these plants have been heavily impacted by the cutting and the fragmentation of forest formations throughout the country. Considering the limited availability of natural resources, threats to species diversity, and the necessity of conservation efforts in light of the rapid exhaustion of natural ecosystems, it is becoming exceedingly important to establish conservation priorities. The present work sought to identify the native medicinal plants harvested for industrial purposes and to establish conservation priorities for the species of highest commercial value. To that end, a survey of Brazilian industrial products that use medicinal plants was undertaken in 54 shops in the city of Recife (Pernambuco, NE Brazil). The survey noted information concerning the commercial name of the product, its plant composition and pharmaceutical presentation, therapeutic indications, as well as the laboratory that produced it. Only native species were considered. A total of 74 different native species used to produce more than 300 types of products were encountered in the present survey. Twelve species demonstrated significant versatility (Species which had the highest numbers of different therapeutic indications and body systems), and 58.33% of these plants were trees. Destructive collecting predominates (58.11%), greatly affecting taxa collected exclusively from wild populations (86.49%). The intensive use of exclusively wild species and the destructive harvesting techniques employed in gathering them create serious problems that will threaten the availability of these resources to future generations.

No abstract